PRA 📈 ProAssurance - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74267C1062
PRA: Insurance, Reinsurance, Liability, Workers' Compensation
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds. The company also provides workers' compensation insurance products, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. The company also participates in Syndicate 1729 at Lloyd's of London for underwriting. It markets its products through independent agencies and brokers, as well as an internal business development team. The company was founded in 1976 and is headquartered in Birmingham, Alabama. Web URL: https://www.proassurance.com
Additional Sources for PRA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PRA Stock Overview
Market Cap in USD | 857m |
Sector | Financial Services |
Industry | Insurance - Property & Casualty |
GiC Sub-Industry | Property & Casualty Insurance |
IPO / Inception | 1991-09-04 |
PRA Stock Ratings
Growth 5y | -45.3% |
Fundamental | 0.94% |
Dividend | 19.7% |
Rel. Strength Industry | -54.7 |
Analysts | 3.2/5 |
Fair Price Momentum | 15.32 USD |
Fair Price DCF | - |
PRA Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 65.5% |
PRA Growth Ratios
Growth Correlation 3m | 74% |
Growth Correlation 12m | 52.7% |
Growth Correlation 5y | -52.5% |
CAGR 5y | -14.62% |
CAGR/Mean DD 5y | -0.31 |
Sharpe Ratio 12m | 0.35 |
Alpha | -3.05 |
Beta | 0.45 |
Volatility | 34.50% |
Current Volume | 920.6k |
Average Volume 20d | 277.6k |
What is the price of PRA stocks?
As of December 22, 2024, the stock is trading at USD 15.76 with a total of 920,592 shares traded.
Over the past week, the price has changed by -5.44%, over one month by -2.52%, over three months by +17.26% and over the past year by +12.99%.
As of December 22, 2024, the stock is trading at USD 15.76 with a total of 920,592 shares traded.
Over the past week, the price has changed by -5.44%, over one month by -2.52%, over three months by +17.26% and over the past year by +12.99%.
Is ProAssurance a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, ProAssurance is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.94 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRA as of December 2024 is 15.32. This means that PRA is currently overvalued and has a potential downside of -2.79%.
Neither. Based on ValueRay Fundamental Analyses, ProAssurance is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.94 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRA as of December 2024 is 15.32. This means that PRA is currently overvalued and has a potential downside of -2.79%.
Is PRA a buy, sell or hold?
ProAssurance has received a consensus analysts rating of 3.20. Therefor, it is recommend to hold PRA.
ProAssurance has received a consensus analysts rating of 3.20. Therefor, it is recommend to hold PRA.
- Strong Buy: 0
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecast for PRA stock price target?
According to ValueRays Forecast Model, PRA ProAssurance will be worth about 16.6 in December 2025. The stock is currently trading at 15.76. This means that the stock has a potential upside of +5.01%.
According to ValueRays Forecast Model, PRA ProAssurance will be worth about 16.6 in December 2025. The stock is currently trading at 15.76. This means that the stock has a potential upside of +5.01%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 18.3 | 15.8% |
Analysts Target Price | 20.5 | 30.1% |
ValueRay Target Price | 16.6 | 5% |